Skip to Content

3138 WPI (Nizatidine 300 mg)

Pill with imprint 3138 WPI is Brown, Capsule-shape and has been identified as Nizatidine 300 mg. It is supplied by Watson Pharmaceuticals.

Nizatidine is used in the treatment of gerd; erosive esophagitis; indigestion; duodenal ulcer; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 3138 WPI

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide